StartGNV Hosts Women in Innovation AMA
StartGNV hosted a live ‘Ask me Anything’ on Thursday, March 25, 2021, to highlight women in Gainesville innovation. The three panelists were UF Innovate | The Hub resident clients Helena Cowley, president and CEO of Oxidien Pharmaceuticals; Victoria Liu, founder of Byppo; and our very own Jennifer Harrell, interim assistant director of UF Innovate | The Hub.
Oxidien Pharmaceuticals Announce Additions to New Strategic Advisory Board
UF Innovate | The Hub resident client Oxidien Pharmaceuticals announced two additions to its newly organized Strategic Advisory Board (SAB).
Arranta Bio Named Honoree in GrowFL Companies to Watch
Arranta Bio is pleased to be among the top 50 second-stage companies in Florida selected as honorees in the 2020 GrowFL Florida... Read More
Oxidien Pharmaceuticals Selected as Winner of Buzz of BIO in Early Stage Entrepreneur Category
UF Innovate | The Hub resident client Oxidien Pharmaceuticals, a clinical-stage biopharmaceutical company mitigating kidney stone disease by treating secondary hyperoxaluria, announced that it... Read More
Oxidien Announces Publication of Clinical Results Demonstrating Significant Reduction in Urinary Oxalate
UF Innovate | The Hub resident client Oxidien Pharmaceuticals, a clinical-stage biopharmaceutical company mitigating kidney stone disease by treating secondary hyperoxaluria, announced the... Read More
Oxidien Pharmaceuticals Announce Addition to Scientific and Medical Advisory Board
UF Innovate | The Hub resident client Oxidien Pharmaceuticals, a clinical-stage biopharmaceutical company developing a best-in-class enzyme therapeutic for an underserved kidney disease... Read More
Selecting a Microbiome CDMO Partner for the Long Term, Arranta Bio Shares
As more microbiome-based therapies progress through the clinic toward approval for market launch, concerns over the lack of outsourcing capacity for process... Read More
Oxidien Pharmaceuticals Receives High Recognition at RESI Conference in Partnership With Women in Bio
UF Innovate | The Hub resident client Oxidien Pharmaceuticals, a clinical-stage biopharmaceutical company mitigating kidney disease by treating secondary hyperoxaluria, announced that its... Read More
Oxidien Among Top Three Winners of Digital RESI June Innovation Challenge
The 3-day Digital RESI June conference announced the Top 3 Winners of the Innovation Challenge. UF Innovate | The Hub resident client Oxidien Pharmaceuticals was... Read More
Arranta Bio Announces Completion of Its Microbiome Process Development Laboratory Expansion and Commitment to Additional Early Clinical GMP Capacity
Arranta Bio, the leading microbiome contract development and manufacturing organization (CDMO), announced the completion of its process development laboratory expansion project and... Read More
